They found that individuals with major depressive disorders (MDD) had lower levels of GLP-1 hormone in their blood compared to healthy controls, and that increasingly lower GLP-1 levels were associated with worsening depression and anxiety scores
Researchers found a duration dependent link between the use of GLP-1s and the cumulative 3-year risk of major adverse cardiovascular events: myocardial infarction, stroke, or all-cause death
Patient education may need to focus more heavily on older age groups
Tirzepatide and semaglutide work through different receptor pathways, and individual results vary
Unfortunately, due to an insurance change, I needed to go off the GLP-1 drug I was taking, and over several months, I watched my total daily insulin needs climb steadily
This happens more often than most people think